Tyrosine Kinase Inhibitors for the Elderly

Until few years ago non-specific cytotoxic agents were considered the tip of the arrow as first line treatment for lung cancer. However; age > 75 was considered a major drawback for this kind of therapy. Few exceptions were made by doctors based on the performance status of the patient. The side...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Cancer
Glavni autori: Hohenforst-Schmidt, Wolfgang, Zarogoulidis, Paul, Steinheimer, Michael, Benhassen, Naim, Tsiouda, Theodora, Baka, Sofia, Yarmus, Lonny, Stratakos, Grigoris, Organtzis, John, Pataka, Athanasia, Tsakiridis, Kosmas, Karapantzos, Ilias, Karapantzou, Chrysanthi, Darwiche, Kaid, Zissimopoulos, Athanasios, Pitsiou, Georgia, Zarogoulidis, Konstantinos, Man, Yan-Gao, Rittger, Harald
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2016
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829555/
https://ncbi.nlm.nih.gov/pubmed/27076850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.14819
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items